Women who are pregnant, planning pregnancy, or not using reliable contraception should not start GLP-1 therapy Personal history of pancreatitis Type 1 diabetes or a history of diabetic ketoacidosis Severe renal impairment Known hypersensitivity to the medication All patients undergo a thorough medical review to identify potential risks before treatment is considered
In May, SAHPRA and the South African Pharmacy Council raided an operation accused of unlawfully producing GLP-1 medicines and seized finished products containing semaglutide and tirzepatide
This page will be updated regularly as new information becomes available
PubMed Central , The Journal of Clinical Endocrinology and Metabolism , vol
It belongs in a class of medication called GLP-1 agonists, which work by stimulating insulin production and slowing the emptying of food out of the stomach, both of which help lower glucose levels
The product label for semaglutide does not list jaundice as a common or expected side effect